#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

Endo Pharmaceuticals: CEO Nancy J. Wysenski

Share on Twitter Share on LinkedIn
Staff writer | Chadds Ford, Pa., USA | August 12, 2009
Nancy J. WysenskiAugust 12, 2009, Chadds Ford, Pa., USA - Endo Pharmaceuticals announced the resignation of Nancy J. Wysenski, Endo chief operating officer, effective September 1.
Ms. Wysenski was appointed Chief Operating Officer on September 6, 2007. She is a 25-year pharmaceutical industry veteran, was most recently the President and CEO of EMD Pharmaceuticals, Inc., the U.S. subsidiary of German-based Merck KGaA for more than seven years.

Prior to joining and co-founding EMD, Ms. Wysenski, was the Senior Vice President of Operations at NetGenics, a start-up company specializing in sequencing software for use in drug discovery. Earlier, Ms. Wysenski held a number of positions of increasing scope and responsibility at Astra Merck, where she rose to Vice President of Sales. During her tenure at Astra Merck, she also served on the company's operating board.

Ms. Wysenski began her pharmaceutical industry career in 1984 at Merck Human Health as a sales representative following a successful career in nursing. On February 23, 2009, Ms. Wysenski was appointed to the Board of Directors of Indevus Pharmaceuticals, Inc.


 LATEST MOVES FROM Pennsylvania 


MORE INSIDE POST